pharmaceuticals

Purdue Backs Fraud Claim Against Sacklers, Amid Scramble for Immunity

In bankruptcy court on July 9, OxyContin manufacturer Purdue Pharma secured an injunction to temporarily stave off lawsuits while it…

July 11, 2024

Walgreens Rolls Out $34.99 Naloxone, as Generics and OTC Gain Ground

Walgreens is rolling out an over-the-counter (OTC) naloxone nasal spray, which it will sell alongside the OTC Narcan it already…

May 16, 2024

The Opioid Settlements Being Paid in Naloxone Don’t Quite Add Up

Amneal Pharmaceuticals, a New Jersey-based manufacturer known for generics, has agreed to settle the 900-plus lawsuits alleging it failed to…

May 7, 2024

Seroquel Gave Me a Reminder That All Drugs Are Merely Tools

Drugs are not good or bad. They are simply morally neutral tools which can help or hurt, depending on context.…

August 30, 2022

DEA’s Rx Drug Take Back Day Branded Fun for All the Family

The worst thing I've seen suggested at one of the Drug Enforcement Administration’s biannual Prescription Drug Take Back days is…

April 29, 2022

Rx Drug Take Back Days Are Unhelpful at Best, Harmful at Worst

The Drug Enforcement Administration really, really wants you to give them your leftover prescription drugs. All week long, in the…

October 22, 2021

Nan Goldin Isn’t Focused on the Sacklers Anymore

On March 10, 2018, photographer and activist Nan Goldin led dozens of protestors to the Sackler Wing of the Metropolitan…

October 19, 2021

Will Missouri’s Opioid Settlement Payout Mean Much for Harm Reduction?

At least 1,921 Missourians died of opioid-involved overdose in 2020, an increase of almost 20 percent from the year before.…

August 4, 2021

The US Faces a Naloxone Shortage at the Worst Possible Time

Life expectancy in the United States plunged by a year and a half in 2020, the worst year-on-year change since…

July 29, 2021

Alzheimer’s Drug Approval “Damages FDA Credibility,” Advocates Say

When the Food and Drug Administration approved a controversial new Alzheimer’s treatment on June 7, it was over widespread expert…

June 21, 2021